Salmeterol Alternatives Compared
Salmeterol | Dupixent (dupilumab) | Omalizumab |
|
---|
Salmeterol | Dupixent (dupilumab) | Omalizumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for COPD - Maintenance, Asthma - Maintenance, Allergic Asthma, Asthma, Bronchospasm Prophylaxis, COPD, COPD - Acute. Salmeterol may also be used for purposes not listed in this medication guide. View more |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Prescription only
Prescribed for Urticaria, Food Allergies, Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps, Asthma - Maintenance, Asthma. Omalizumab may also be used for purposes not listed in this medication guide. View more |
Related suggestions Asthma, Maintenance
Popular comparisons
|
|||||||
More about Salmeterol | More about Dupixent (dupilumab) | More about Omalizumab | ||||||||
Ratings & Reviews | ||||||||||
Salmeterol has an average rating of 7.8 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
Dupixent has an average rating of 7.1 out of 10 from a total of 480 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
Omalizumab has an average rating of 7.7 out of 10 from a total of 257 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dupixent prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Serevent Diskus |
N/A |
Xolair | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
5.5 hours |
N/A |
624 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 434 drugs are known to interact with Salmeterol:
|
A total of 89 drugs are known to interact with Dupixent:
|
A total of 25 drugs are known to interact with Omalizumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
September 19, 1997 |
March 28, 2017 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
|||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.